Katsura Tsukamoto

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 9

Top Venues

Journal of medical economics

Therapeutic innovation & regulatory science

Journal of clinical pharmacy and therapeutics

The International journal of health planning and management

Gifu Pharmaceutical University

Gifu Pharmaceutical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Gifu Pharmaceutical University

Japan

Professor :: Global Regulatory Science

Education History

Gifu Pharmaceutical University

Japan

PHD :: Pharmacology

Publications

Gentaro Tajima, Naoki Matsumaru, Katsura Tsukamoto
Impact of expedited programs in the United States, as foreign regulatory factors, on clinical development time in Japan. Journal of clinical pharmacy and therapeutics 47 (9) (2022)
Keiichi Sawachi, Naoki Matsumaru, Katsura Tsukamoto
Clinical development of anticancer drugs can be enhanced using efficacy data of small population clinical trials. Journal of clinical pharmacy and therapeutics 47 (9) (2022)
Shinya Ohno, Yirong Chen, Hiroyuki Sakamaki, Naoki Matsumaru, Motoaki Yoshino, Katsura Tsukamoto
Burden of caring for Alzheimer's disease or dementia patients in Japan, the US, and EU: results from the National Health and Wellness Survey: a cross-sectional survey. Journal of medical economics 24 (1) (2021)
Shinya Ohno, Yirong Chen, Hiroyuki Sakamaki, Naoki Matsumaru, Motoaki Yoshino, Katsura Tsukamoto
Humanistic burden among caregivers of patients with Alzheimer's disease or dementia in Japan: a large-scale cross-sectional survey. Journal of medical economics 24 (1) (2021)
Tomoko Matsumoto, Naoki Matsumaru, Paul Scuffham, Pieter Neels, Katsura Tsukamoto
Alternative New Mono-scaled Quantitative Benefit-Risk Assessment of Human Papillomavirus Vaccine in Japan. Therapeutic innovation & regulatory science 55 (1) (2020)
Shinya Ohno, Yirong Chen, Hiroyuki Sakamaki, Naoki Matsumaru, Katsura Tsukamoto
Factors associated with humanistic burden and indirect cost among patients with cancer in Japan. Journal of medical economics 23 (12) (2020)
Kaori Kido, Katsura Tsukamoto
The International journal of health planning and management 35 (1) (2019)
Kaori Kido, Naoki Matsumaru, Katsura Tsukamoto
Health Technology Assessment in Japan: A Pharmaceutical Industry Perspective. Therapeutic innovation & regulatory science 53 (4) (2018)
Katsura Tsukamoto, Miriam Cnop, Daichi Mori, Shoen Kume, Takayuki Anazawa, Masako Doi, Kazuhiko Chikazawa, Naoki Matsumaru
Future Perspectives for the Treatment of Diabetes: Importance of a Regulatory Framework. Therapeutic innovation & regulatory science 53 (4) (2018)

Katsura Tsukamoto.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Katsura Tsukamoto